THUNDER BIOTECH, INC.

Profile

Company Names

THUNDER BIOTECH, INC.

Addresses

395 COUGAR BLVD., SUITE 103, PROVO, UT 84604

180 NORTH UNIVERSITY AVENUE, SUITE 820, PROVO, UT 84601

730 EAST 100 NORTH, ALPINE, UT 84004

Phone Numbers

801-367-9298
801-376-6166

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$24,514,789.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-02-09 
$100,000.00 
$2,500,000.00 
$2,400,000.00 
Debt 
6
2022-09-16 
$1,000,000.00 
$20,000,000.00 
$19,000,000.00 
Debt 
5
2021-11-30 
$4,020,000.00 
$15,000,000.00 
$10,980,000.00 
Equity 
4
2020-10-05 
$8,320,515.00 
$10,000,000.00 
$1,679,485.00 
Equity 
3
2019-09-30 
$9,979,274.00 
$10,000,000.00 
$20,726.00 
Equity 
2
2017-10-05 
$325,000.00 
$18,000,000.00 
$17,675,000.00 
Debt 
1
2017-01-30 
$770,000.00 
$2,000,000.00 
$1,230,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
J. 
ANTHONY 
ANTONELLI 
DIRECTOR
JEFF 
 
HONE 
EXECUTIVE OFFICER, DIRECTOR
D. 
BRENT 
ISRAELSEN 
EXECUTIVE OFFICER, DIRECTOR
MORRIS 
 
LINTON 
EXECUTIVE OFFICER, DIRECTOR
KENT 
 
MISENER 
DIRECTOR
KENT 
A. 
MISENER 
DIRECTOR
ROBERT 
P.K. 
MOONEY 
EXECUTIVE OFFICER, DIRECTOR
BARRY 
 
MOWER 
DIRECTOR
BARRY 
D. 
MOWER 
DIRECTOR
JEFFREY 
 
NELSON 
DIRECTOR
JEFFREY 
R. 
NELSON 
DIRECTOR
KIM 
 
O-NEILL 
EXECUTIVE OFFICER, DIRECTOR
KIM 
L. 
O-NEILL 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
PETERSON 
DIRECTOR
D. 
TOD 
SCHULTHESS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
D. 
TODD 
SCHULTHESS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
STEVEN 
 
TANNER 
DIRECTOR
STEVEN 
A. 
TANNER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-02-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MANN MANN JENSEN PARTNERS LP